GIST Support International - logo

GIST Support International - XL765
GIST Imagery

XL765

This drug, under preclinical development by Exelixis, inhibits both PI3K and mTOR.  It is expectd to enter a Phase I trial late in 2007.

For information at the site of the manufacturer click here.



back to top